Safety of Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis (Hlh): Relationship to treatment Exposure

被引：0
|
作者：
Jordan, Michael [1 ,2 ,3 ,4 ]
Locatelli, Franco [5 ,6 ]
Jacqmin, Philippe [7 ]
Laveille, Christian [8 ]
Snoeck, Eric [9 ]
de Min, Cristina [10 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Immunobiol, Cincinnati, OH 45229 USA
[2] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Bone Marrow Transplantat, Cincinnati, OH 45229 USA
[3] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Immune Deficiency, Cincinnati, OH 45229 USA
[4] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[5] Sapienza Univ Rome, Dept Pediat, Rome, Italy
[6] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol Oncol & Cell & Gene Therapy, Rome, Italy
[7] MnS Modelling & Simulat, Dinant, Belgium
[8] Calvagone Sarl, Liergues, France
[9] Luccio BV, Meerhout, Belgium
[10] Swedish Orphan Biovitrum AG Sobi, Basel, Switzerland
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [1] Safety of Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis (HLH): Relationship to Treatment Exposure
    Jordan, Michael B.
    Locatelli, Franco
    Jacqmin, Philippe
    Laveille, Christian
    Snoeck, Eric
    Min, Cristinade
    BLOOD, 2021, 138
  • [2] EMAPALUMAB EXPOSURE-SAFETY RELATIONSHIP IN PATIENTS WITH PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
    Jordan, Michael
    Locatelli, Franco
    Jacqmin, Philippe
    Laveille, Christian
    Snoeck, Erik
    de Min, Cristina
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [3] Exposure-safety relationship for patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab
    Jordan, Michael B.
    Locatelli, Franco
    PEDIATRIC BLOOD & CANCER, 2024, 71 (02)
  • [4] Safety and Efficacy of Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis
    Locatelli, Franco
    Jordan, Michael B.
    Allen, Carl E.
    Cesaro, Simone
    Rizzari, Carmelo
    Rao, Anupama
    Degar, Barbara
    Garrington, Timothy
    Sevilla, Julian
    Putti, Maria Caterina
    Fagioli, Franca
    Ahlmann, Martina
    Dapena, Jose-Luis
    Grom, Alexei A.
    De Benedetti, Fabrizio
    Ferlin, Walter Giovanni
    Ballabio, Maria
    De Min, Cristina
    BLOOD, 2018, 132
  • [5] EMAPALUMAB IN PEDIATRIC PATIENTS WITH PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: SAFETY & EFFICACY
    Allen, Carl
    Locatelli, Franco
    Jordan, Michael
    Cesaro, Simone
    Rizzari, Carmelo
    Rao, Anupama
    Garrington, Timothy
    Sevilla, Julian
    Putti, Maria Caterina
    Fagioli, Franca
    Ahlmann, Martina
    Dapena, Jose-Luis
    Grom, Alexei
    De Benedetti, Fabrizio
    Ferlin, Walter Giovanni
    Ballabio, Maria
    De Min, Cristina
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [6] Safety and efficacy of emapalumab in pediatric patients with primary hemophagocytic lymphohistiocytosis (PHLH)
    Locatelli, Franco
    Jordan, Michael B.
    Allen, Carl E.
    Cesaro, Simone
    Sevilla, Julian
    Rao, Anupama
    Ahlmann, Martina
    Dapena, Jose-Luis
    Degar, Barbara
    Fagioli, Franca
    Garrington, Timothy
    Henry, Michael
    Putti, Maria Caterina
    Rizzari, Carmelo
    De Benedetti, Fabrizio
    Grom, Alexei A.
    Ferlin, Walter Giovanni
    Ballabio, Maria
    de Min, Cristina
    BONE MARROW TRANSPLANTATION, 2019, 54 : 94 - 95
  • [7] Emapalumab-lzsg for the Treatment of Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis
    Jordan, Michael
    Locatelli, Franco
    Allen, Carl
    Cesaro, Simone
    Rizzari, Carmelo
    Rao, Anupama
    Dega, Barbara
    Garrington, Timothy
    Sevilla, Julian
    Putti, Maria Caterina
    Fagioli, Franca
    Ahlmann, Martina
    Dapena, Jose-Luis
    Grom, Alexei
    De Benedetti, Fabrizio
    Ferlin, Walter Giovanni
    Ballabio, Maria
    De Min, Cristina
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S118 - S119
  • [8] SAFETY OF EMAPALUMAB IN PEDIATRIC PATIENTS WITH PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH): FINDINGS FROM THE PRIMARY ANALYSIS OF THE PIVOTAL PHASE 2/3 STUDY
    Locatelli, Franco
    Jordan, Michael
    Allen, Carl
    Cesaro, Simone
    Rizzari, Carmelo
    Rao, Anupama
    Degar, Barbara
    Garrington, Timothy
    Sevilla, Julian
    Putti, Maria Caterina
    Fagioli, Franca
    Ahlmann, Martina
    Dapena Diaz, Jose-Luis
    Henry, Michael
    De Benedetti, Fabrizio
    Grom, Alexei
    Jacqmin, Philippe
    Ballabio, Maria
    de Min, Cristina
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [9] Analysis of Hospitalization Events in Patients with Primary Hemophagocytic Lymphohistiocytosis (HLH) Treated with Emapalumab
    Wilson, Koo
    Pochopien, Michal
    Nazir, Jameel
    Rao, Anupama
    Locatelli, Franco
    BLOOD, 2020, 136
  • [10] EMAPALUMAB TREATMENT PATTERNS/OUTCOMES IN PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: REAL-HLH STUDY
    Allen, Carl
    Chandrakasan, Shanmuganathan
    Jordan, Michael
    Leiding, Jennifer
    Oladapo, Abiola
    Pednekar, Priti
    Walkovich, Kelly
    Yee, John
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S62 - S62
12345